Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals-Reference-Cited by-同舟云学术

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals

Published:2003-03 Issue:5 Volume:91 Page:11-17
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Shepherd James,Hunninghake Donald B,Barter Philip,McKenney James M,Hutchinson Howard G

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001

2. Prevention of coronary heart disease in clinical practice;Eur Heart J,1998

3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries;Eur Heart J,2001

4. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease;Sueta;Am J Cardiol,1999

5. The lipid treatment assessment project (L-TAP);Pearson;Arch Intern Med,2000

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan, polyethylene oxide/polycaprolactone electrospun core/shell nanofibrous mat containing rosuvastatin as a novel drug delivery system for enhancing human mesenchymal stem cell osteogenesis;Frontiers in Molecular Biosciences;2023-07-13

2. Current Research on the Influence of Statin Treatment on Rotator Cuff Healing;Clinics in Orthopedic Surgery;2023

3. A step further in uncontrolled hyperlipidemia;Galenika Medical Journal;2022

4. Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans;Frontiers in Pharmacology;2021-06-09

5. Rho-Kinase inhibitors ameliorate diclofenac-induced cardiotoxicity in chloroquine-treated adjuvant arthritic rats;Life Sciences;2020-08